Contact Us

April 4, 2022

Vivace Therapeutics to Present New Data from Preclinical Combination Studies of VT3989 and Osimertinib at American Association for Cancer Research (AACR) Annual Meeting 2022

Research and Publications

VIEW ALL

March 7, 2013

The Hippo Pathway and Human Cancer

READ MORE

November 5, 2015

Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer

READ MORE

June 28, 2017

Vivace Therapeutics Comes out of Stealth with $40 Million to Turn Novel Biology into First-in-Class Cancer Therapeutics

READ MORE